Assessing Hepatitis B Reactivation Risk With Rituximab and Recent Intravenous Immunoglobulin Therapy

Claire Dysart1, Karine Rozenberg-Ben-Dror2, Mariscelle Sales3

  • 1Department of Veterans Affairs, Clement J. Zablocki Veterans Affairs Medical Center, Milwaukee, Wisconsin, USA.